Herasight vs Nucleus: what our 2025 analysis found
Decisions and perspectives
What Herasight found in five 2025 Nucleus risk reports, why validation matters, and how that analysis differs from an assessment of today's models.
Read articleResearch, explanations, and practical guidance for families considering embryo screening.
35 articlesPage 1 of 7
Featured article
Decisions and perspectives
What Herasight found in five 2025 Nucleus risk reports, why validation matters, and how that analysis differs from an assessment of today's models.
Read articleDecisions and perspectives
We examine the evidence behind Juniper's pregnancy-loss claims and explain what would show whether PGT-G improves IVF outcomes.
Read articleConditions and traits
If you're going through IVF and are testing your embryos for the risk of developing complex diseases, you may wonder whether it’s also possible to test for intelligence. The answer is yes: intelligence is moderately to highly heritable (Plomin & Deary, 2015), and Herasight has developed a powerful polygenic predictor of intelligence (Wolfram et al., 2026).
Read articleIVF and PGT guides
The cost of egg freezing usually arrives as a single figure on a clinic page, weeks before the first consultation. It's a five-figure number large enough to change a year's savings plan, and a careful reader can see it against her bank balance long before she knows what's actually in it.
Read articleDecisions and perspectives
The word "eugenics" is occasionally associated with embryo screening. But the word “eugenics” is ambiguous between voluntarily selecting children with various genetic advantages, states intervening to shape the traits of populations, and states engaging in programs that are morally objectionable, such as mass murder in the name of eugenics.
Read article